Rodent models of diverse forms of synucleinopathy, such as PD, and DLB, have been valuable in determining both vulnerability factors and the specific contribution of α-synuclein-induced pathology to the phenotype [30]–[34]. This evidence concerns the gene SNCA and Parkinson disease.